MIR106A |
|
microRNA 106a
|
|
|
0.524 |
0.846 |
SCHLAP1 |
|
SWI/SNF complex antagonist associated with prostate cancer 1
|
|
|
0.751 |
0.192 |
ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
ERBB3 |
P21860
|
erb-b2 receptor tyrosine kinase 3
|
Kinase
|
1.7E-15 |
0.448 |
0.808 |
TXNDC5 |
Q8NBS9
|
thioredoxin domain containing 5
|
|
4.9E-13 |
0.615 |
0.577 |
MTHFR |
P42898
|
methylenetetrahydrofolate reductase
|
|
3.2E-10 |
0.337 |
0.885 |
NAGK |
Q9UJ70
|
N-acetylglucosamine kinase
|
Kinase
|
4.6E-09 |
0.931 |
0.154 |
TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
ANXA4 |
P09525
|
annexin A4
|
|
1.2E-08 |
0.599 |
0.692 |
ETV4 |
P43268
|
ETS variant transcription factor 4
|
Transcription factor
|
2.9E-08 |
0.545 |
0.500 |
ABCC4 |
O15439
|
ATP binding cassette subfamily C member 4
|
Transporter
|
1.1E-07 |
0.536 |
0.769 |
ANXA1 |
P04083
|
annexin A1
|
|
1.2E-07 |
0.442 |
0.885 |
GDF15 |
Q99988
|
growth differentiation factor 15
|
Signaling
|
3.0E-07 |
0.429 |
0.808 |
ALOX5 |
P09917
|
arachidonate 5-lipoxygenase
|
Enzyme
|
1.2E-06 |
0.447 |
0.885 |
PLAU |
P00749
|
plasminogen activator, urokinase
|
Enzyme
|
2.3E-06 |
0.425 |
0.923 |
CYP19A1 |
P11511
|
cytochrome P450 family 19 subfamily A member 1
|
Enzyme
|
1.7E-05 |
0.410 |
0.885 |
VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
MLH1 |
P40692
|
mutL homolog 1
|
Nucleic acid binding
|
3.4E-05 |
0.399 |
0.808 |
VIP |
P01282
|
vasoactive intestinal peptide
|
Signaling
|
4.2E-04 |
0.437 |
0.846 |
NPPA |
P01160
|
natriuretic peptide A
|
|
5.5E-04 |
0.505 |
0.769 |
PRNP |
F7VJQ1 P04156
|
prion protein
|
|
6.3E-04 |
0.445 |
0.923 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
PLAUR |
Q03405
|
plasminogen activator, urokinase receptor
|
|
5.3E-03 |
0.536 |
0.731 |